These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37915752)

  • 1. Survivin as a mediator of stiffness-induced cell cycle progression and proliferation of vascular smooth muscle cells.
    Biber JC; Sullivan A; Brazzo JA; Heo Y; Tumenbayar BI; Krajnik A; Poppenberg KE; Tutino VM; Heo SJ; Kolega J; Lee K; Bae Y
    APL Bioeng; 2023 Dec; 7(4):046108. PubMed ID: 37915752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin regulates intracellular stiffness and extracellular matrix production in vascular smooth muscle cells.
    Krajnik A; Nimmer E; Brazzo JA; Biber JC; Drewes R; Tumenbayar BI; Sullivan A; Pham K; Krug A; Heo Y; Kolega J; Heo SJ; Lee K; Weil BR; Kim DH; Gupte SA; Bae Y
    APL Bioeng; 2023 Dec; 7(4):046104. PubMed ID: 37868708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining the Stiffness-Sensitive Transcriptome in Human Vascular Smooth Muscle Cells Identifies Long Noncoding RNA Stiffness Regulators.
    Yu CK; Xu T; Assoian RK; Rader DJ
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):164-173. PubMed ID: 29051139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of PI3K regulatory subunit p55γ as a novel inhibitor of vascular smooth muscle cell proliferation and neointimal formation.
    Li G; Xie N; Yao Y; Zhang Y; Guo J; Feng Y; Lv F; Xiao RP; Cao CM
    Cardiovasc Res; 2015 Jan; 105(1):75-85. PubMed ID: 25388664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
    Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
    Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation.
    Zhang C; Chen D; Maguire EM; He S; Chen J; An W; Yang M; Afzal TA; Luong LA; Zhang L; Lei H; Wu Q; Xiao Q
    Cardiovasc Res; 2018 Mar; 114(3):443-455. PubMed ID: 29206900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia.
    Ko DS; Kang J; Heo HJ; Kim EK; Kim K; Kang JM; Jung Y; Baek SE; Kim YH
    Int J Biol Sci; 2022; 18(13):5154-5167. PubMed ID: 35982907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration.
    Chen Q; Yang F; Guo M; Wen G; Zhang C; Luong le A; Zhu J; Xiao Q; Zhang L
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):75-86. PubMed ID: 26493107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models.
    Chappell J; Harman JL; Narasimhan VM; Yu H; Foote K; Simons BD; Bennett MR; Jørgensen HF
    Circ Res; 2016 Dec; 119(12):1313-1323. PubMed ID: 27682618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cezanne is a critical regulator of pathological arterial remodelling by targeting β-catenin signalling.
    An W; Luong LA; Bowden NP; Yang M; Wu W; Zhou X; Liu C; Niu K; Luo J; Zhang C; Sun X; Poston R; Zhang L; Evans PC; Xiao Q
    Cardiovasc Res; 2022 Jan; 118(2):638-653. PubMed ID: 33599243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation.
    Li P; Zhu N; Yi B; Wang N; Chen M; You X; Zhao X; Solomides CC; Qin Y; Sun J
    Circ Res; 2013 Oct; 113(10):1117-27. PubMed ID: 24014830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.
    Feng S; Gao L; Zhang D; Tian X; Kong L; Shi H; Wu L; Huang Z; Du B; Liang C; Zhang Y; Yao R
    Int J Biol Sci; 2019; 15(12):2615-2626. PubMed ID: 31754334
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokine-induced apoptosis inhibitor 1 (CIAPIN1) accelerates vascular remodelling via p53 and JAK2-STAT3 regulation in vascular smooth muscle cells.
    Han JH; Heo KS; Myung CS
    Br J Pharmacol; 2021 Nov; 178(22):4533-4551. PubMed ID: 34289085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium chloride inhibits vascular smooth muscle cell proliferation and migration and alleviates injury-induced neointimal hyperplasia via induction of PGC-1α.
    Wang Z; Zhang X; Chen S; Wang D; Wu J; Liang T; Liu C
    PLoS One; 2013; 8(1):e55471. PubMed ID: 23383200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells.
    Nabzdyk CS; Lancero H; Nguyen KP; Salek S; Conte MS
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1841-9. PubMed ID: 21856925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.